MADRID, 29 Ene. (EUROPA PRESS) –
Grifols shares rose 1.3% around 9:15 a.m. this Monday after filing a lawsuit against Gotham City Research, the fund’s director and founder, Daniel, in the United States District Court of the Southern District of New York. Yu, General Industrial Partners, Cyrus de Weck and their investees.
Grifols, which led the rises of the Ibex 35 along with Repsol, rose 1.32%, to 9.686 euros per share.
The blood products firm reported this Friday, after the market closed to the National Securities Market Commission (CNMV) that, following reports that questioned its accounting and solvency, it has filed with the United States District Court of Southern District of New York a lawsuit against Gotham City Research, the director and founder of the fund, Daniel Yu, General Industrial Partners, Cyrus de Weck and its investees to request compensation for the financial and reputational damages caused to the company and its shareholders.
The complaint alleged that the defendants obtained “a substantial short position” in Grifols by subsequently publishing and distributing a report “containing falsehoods about Grifols’ accounting, communications, finances, and integrity.”
In this lawsuit, the Catalan company requested the application of precautionary measures so that the defendants retract and do not persist in their actions, while at the same time demanding financial compensation that has not been quantified.
Grifols also requests before the New York court that the defendants be held “fully responsible” for the “illegal behavior” alleged in the lawsuit.
